Home › Encyclopedia › Larazotide: Research Status, Trials, and Identity
Research / Unapproved

Larazotide: Research Status, Trials, and Identity

Molecular formulaC32H55N9O10
Molecular weight725.8 g/mol
Registered trials29
PubChem CID9810532

What larazotide is

Larazotide is an investigational peptide that does not carry an approved regulatory label. It has the molecular formula C32H55N9O10 and a molecular weight of about 725.8 (PubChem CID 9810532). Because no label exists, there is no approved indication, mechanism statement, or brand name to report here.

Trial footprint

Larazotide has been associated with 29 registered clinical trials. Sample records in this dataset include a completed phase 2 study assessing its efficacy for celiac disease (NCT00492960). Other entries in the broader trial set reference related compounds and programs, such as a completed phase 3 study and a terminated phase 2 long-term safety study for a separate Fabry disease therapy (migalastat hydrochloride), reflecting the shared dataset these records were drawn from.

FAQ

Is larazotide an FDA-approved drug?
No. Larazotide does not have an approved regulatory label. It remains an investigational compound studied in clinical research settings.
What is larazotide made of?
Larazotide is a peptide with the molecular formula C32H55N9O10 and a molecular weight of about 725.8. Its PubChem entry is catalogued under CID 9810532.
What conditions has larazotide been studied for?
Available trial records show larazotide studied in the context of celiac disease, including a completed phase 2 study. A total of 29 registered trials reference this compound.
Are there side effect reports available for larazotide?
No side effect report data is available in this dataset for larazotide. Readers should rely on direct review of individual trial results for safety information.
Has larazotide been proven effective?
This dataset does not include label or efficacy conclusions for larazotide, since no approved indication exists. Registered trials, including completed and terminated studies, reflect ongoing research rather than established clinical benefit.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: ClinicalTrials.gov PubChem

Updated 2026-11-07